GMD — Antisera, Latex Agglutination, Cryptococcus Neoformans Class II

FDA Device Classification

FDA product code GMD covers "Antisera, Latex Agglutination, Cryptococcus Neoformans", a Class II medical device regulated under 21 CFR 866.3165. Submissions are reviewed by the Microbiology panel. At least 10 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
GMD
Device Class
Class II
Regulation Number
866.3165
Submission Type
510(k) Exempt
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K112422Immuno-MycologicsCRAG LATERAL FLOW ASSAY (LFA)Mar 28, 2012
K102286Immuno-MycologicsCRAG LATERAL FLOW ASSAY (CRAG LFA)Jul 20, 2011
K930418Trinity LaboratoriesCRYPTO-LEX SYSTEMFeb 17, 1994
K933997Alexon BiomedicalPROSPECT ENTAMOEBA HISTOLYTICA MICROPLATE ASSAYNov 22, 1993
K894845Meridian Diagnostics(CALAS(TM)) W/ADD'L REAGENT CALAS(TM) PRONASESep 8, 1989
K812188American Scientific ProductsCRYPTOCOCCAL ANTIGEN LATEX AGGLUTIAug 31, 1981
K810510Immuno-MycologicsYA-CRYPTO ANTIBODY TUBE AGGLUTINATIONMar 20, 1981
K792693Meridian DiagnosticsCRYPTOCOCCUS NEOFORMANS ANTISERUM, LATEXJan 21, 1980
K791382Immuno-MycologicsCRYPTOCOCCAL ANTIGEN LATEX AGGLUTINATIONAug 16, 1979
K780526I MCRYPTOCOCCAL ANTIGEN LATEX AGG. SYSTEMApr 28, 1978

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.